Orthofix Medical (OFIX) Finished Goods (2011 - 2026)

Orthofix Medical has disclosed Finished Goods across 16 years of filings, most recently posting $87.7 million for Q1 2026.

• Quarterly Finished Goods fell 4.21% year-over-year to $87.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87.7 million (down 4.21% YoY) and the FY2025 annual result came in at $86.2 million, down 18.18% from the prior year.
• Finished Goods improved to $87.7 million in Q1 2026, from $86.2 million in the prior quarter.
• Over five years, Finished Goods peaked at $140.7 million in Q3 2023 and troughed at $24.6 million in Q1 2022.
• A 5-year average of $97.6 million and a median of $91.6 million in 2025 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2023 — Finished Goods surged 471.49% — and 2025, when it plunged 31.16%.
• Tracing OFIX's Finished Goods over 5 years: stood at $63.9 million in 2022, then surged by 119.6% to $140.3 million in 2023, then slipped by 24.89% to $105.4 million in 2024, then slipped by 18.18% to $86.2 million in 2025, then advanced by 1.79% to $87.7 million in 2026.
• Business Quant data shows OFIX's Finished Goods at $87.7 million in Q1 2026, $86.2 million in Q4 2025, and $88.3 million in Q3 2025.